Your browser doesn't support javascript.
loading
How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
Beyer, Katharina; Lawlor, Ailbhe; Remmers, Sebastiaan; Bezuidenhout, Carla; Gómez Rivas, Juan; Venderbos, Lionne D F; Smith, Emma J; Gandaglia, Giorgio; MacLennan, Steven; MacLennan, Sara J; Bjartell, Anders; Briganti, Alberto; Cornford, Philip; Evans-Axelsson, Susan; Ribal, Maria J; N'Dow, James; Briers, Erik; Roobol, Monique J; Van Hemelrijck, Mieke.
Afiliação
  • Beyer K; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Lawlor A; Translational Oncology and Urology Research, King's College London, London, UK.
  • Remmers S; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Bezuidenhout C; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Gómez Rivas J; Department of Urology, Clínico San Carlos University Hospital, Madrid, Spain.
  • Venderbos LDF; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Smith EJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Gandaglia G; Department of Urology, Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • MacLennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland.
  • MacLennan SJ; Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland.
  • Bjartell A; Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
  • Briganti A; Department of Urology, Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cornford P; Department of Translational Medicine, Lund University, Lund, Sweden.
  • Evans-Axelsson S; Medical Affairs Oncology, Bayer AB, Stockholm, Sweden.
  • Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Briers E; Patient advocate, Hasselt, Belgium.
  • Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK.
Eur Urol Open Sci ; 62: 1-7, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38585208
ABSTRACT
Background and

objective:

The ability of health care professionals to communicate with patients compassionately and effectively is crucial for shared decision-making, but little research has investigated patient-clinician communication. As part of PIONEER-an international Big Data Consortium led by the European Association of Urology to answer key questions for men with prostate cancer (PCa), funded through the IMI2 Joint Undertaking under grant agreement 777492- we investigated communication between men diagnosed with PCa and the health care professional(s) treating them across Europe.

Methods:

We used the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Communication 26, which was shared via the PIONEER and patient organisations on March 11, 2022. We sought men who spoke French, Italian, Spanish, German, Dutch, or English who were diagnosed with PCa and were undergoing or had already received treatment for their PCa. Results and

limitations:

A total of 372 men reported that they communicated with their clinician during either the diagnostic or the treatment period. Overall, the majority of participants reported positive experiences. However, important opportunities to enhance communication were identified, particularly with regard to correcting misunderstandings, understanding the patient's preferred approach to information presentation, addressing challenging questions, supporting the patient's comprehension of information, attending to the patient's emotional needs, and assessing what information had already been given to patients about their disease and treatment, and how much of it was understood. Conclusions and clinical implications These results help us to identify gaps and barriers to shared treatment decision making. This knowledge will help devise measures to improve patient-health care professional communication in the PCa setting. Patient

summary:

As part of the PIONEER initiative, we investigated the communication between men diagnosed with prostate cancer and their health care professionals across Europe. A total of 372 men from six different countries participated in the study. Most participants reported positive experiences, but areas where communication could be improved were identified. These included addressing misunderstandings, tailoring the presentation of information to the patient's preferences, handling difficult questions, supporting emotional needs, and assessing the patient's understanding of their diagnosis and treatment.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article